6/6/24 20:37 | 6/4/24 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | | S | -182 | 22.00 | 0 | -8 | -2 | 349 | D | | | | | | | | | | | | | | |
5/15/24 19:44 | 5/13/24 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | | M.d | 229 | 19.57 | 0 | 12 | 4 | 339 | D | | | | | | | | | | | | | | |
5/15/24 19:44 | 5/13/24 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | | S.d | -233 | 21.37 | 0 | -11 | -3 | 339 | D | | | | | | | | | | | | | | |
3/14/23 20:22 | 3/10/23 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | | M.d | 252 | 6.30 | 0 | 40 | 14 | 317 | D | | | | | | | | | | | | | | |
3/14/23 20:22 | 3/10/23 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | | S.d | -254 | 16.61 | 0 | -15 | -5 | 317 | D | | | | | | | | | | | | | | |
4/6/22 20:08 | 4/4/22 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | | M.d | 125 | 3.13 | 0 | 40 | 17 | 273 | D | | | | | | | | | | | | | | |
4/6/22 20:08 | 4/4/22 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | | S.d | -154 | 23.00 | 0 | -7 | -2 | 273 | D | | | | | | | | | | | | | | |
3/31/21 21:02 | 3/29/21 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | | M.d | 135 | 3.38 | 0 | 40 | 21 | 232 | D | | | | | | | | | | | | | | |
3/31/21 21:02 | 3/29/21 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | | S.d | -141 | 22.64 | 0 | -6 | -3 | 232 | D | | | | | | | | | | | | | | |
11/13/20 20:18 | 11/10/20 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Wyszomierski Jack L | CA | D | | M.d | 363 | 5.82 | 0 | 62 | 46 | 198 | D | | | | | | | | | | | | | | |
11/13/20 20:18 | 11/10/20 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Wyszomierski Jack L | CA | D | | S.d | -701 | 20.61 | 0 | -34 | -15 | 198 | D | | | | | | | | | | | | | | |
4/3/20 20:38 | 4/3/20 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Wyszomierski Jack L | CA | D | | M.d | 226 | 5.03 | 0 | 45 | 39 | 162 | D | | | | | | | | | | | | | | |
4/3/20 20:38 | 4/3/20 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Wyszomierski Jack L | CA | D | | S.d | -229 | 16.57 | 0 | -14 | -8 | 162 | D | | | | | | | | | | | | | | |
4/3/19 20:09 | 4/1/19 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Wyszomierski Jack L | CA | D | | M.d | 115 | 4.39 | 0 | 26 | 28 | 120 | D | | | | | | | | | | | | | | |
4/3/19 20:09 | 4/1/19 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Wyszomierski Jack L | CA | D | | S.d | -187 | 23.97 | 0 | -8 | -6 | 120 | D | | | | | | | | | | | | | | |
4/18/18 20:12 | 4/16/18 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Wyszomierski Jack L | CA | D | | M.d | 294 | 9.82 | 0 | 30 | 47 | 94 | D | | | | | | | | | | | | | | |
4/18/18 20:12 | 4/16/18 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Wyszomierski Jack L | CA | D | | S.d | -303 | 20.25 | 0 | -15 | -14 | 94 | D | | | | | | | | | | | | | | |
3/31/17 18:35 | 3/31/17 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Wyszomierski Jack L | CA | D | | M.d | 105 | 10.53 | 33 | 10 | 16 | 73 | D | 725 | 430 | 59 | 39 | -6 | -2 | 4 | -1 | -2 | -6 | 7 | | | |
3/31/17 18:35 | 3/31/17 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Wyszomierski Jack L | CA | D | | S.d | -111 | 21.57 | 33 | -5 | -7 | 73 | D | 725 | 430 | 59 | 39 | -6 | -2 | 4 | -1 | -2 | -6 | 7 | | | |
5/31/16 19:32 | 5/28/16 | XOMA | Xoma Corp | DE | Health | Drug | Pharmaceutical Preparations | Wyszomierski Jack L | CA | D | | M.d | 0 | 0.00 | 1 | 3 | 4 | 81 | D | -83 | -80 | -49 | -8 | -20 | -3 | 1 | 1 | -3 | 0 | -34 | -16 | -52 | |
5/18/16 16:46 | 5/17/16 | SITE | Siteone Landscape Supply, Inc. | DE | Ag | Ag | Agricultural Services | Wyszomierski Jack L | GA | D | | P | 105 | 21.00 | 33 | 5 | 175 | 8 | D | | | | | | | | 5 | -3 | -1 | -4 | 33 | 18 | |
6/1/15 18:24 | 5/28/15 | XOMA | Xoma Corp | DE | Health | Drug | Pharmaceutical Preparations | Wyszomierski Jack L | CA | D | | M.d | 0 | 0.00 | 9 | 6 | 8 | 78 | D | -15 | -17 | -36 | -5 | -5 | -5 | 4 | 5 | -1 | 3 | 5 | -76 | -61 | -80 |
11/17/14 17:45 | 11/13/14 | XOMA | Xoma Corp | DE | Health | Drug | Pharmaceutical Preparations | Wyszomierski Jack L | CA | D | | M.d | 0 | 0.00 | 5 | 4 | 14 | 36 | D | 47 | -5 | 4 | -10 | -3 | -11 | -2 | -3 | 2 | 16 | 4 | -8 | -15 | -68 |
5/29/14 17:48 | 5/28/14 | XOMA | Xoma Corp | DE | Health | Drug | Pharmaceutical Preparations | Wyszomierski Jack L | CA | D | | M.d | 0 | 0.00 | 7 | 6 | 28 | 26 | D | 73 | -2 | 0 | -54 | -1 | -2 | 14 | 7 | -2 | -3 | 9 | 4 | 25 | -15 |
11/15/13 19:03 | 11/13/13 | XOMA | Xoma Corp | DE | Health | Drug | Pharmaceutical Preparations | Wyszomierski Jack L | CA | D | | M.d | 0 | 0.00 | 7 | 4 | 62 | 12 | D | 161 | 54 | -2 | 5 | -24 | -13 | -4 | 11 | -6 | -2 | 33 | 80 | -10 | -6 |
5/29/13 16:20 | 5/28/13 | XOMA | Xoma Corp | DE | Health | Drug | Pharmaceutical Preparations | Wyszomierski Jack L | CA | D | | M.d | 8 | 2.69 | 4 | 3 | 62 | 7 | D | 45 | 76 | 50 | 66 | 19 | 31 | 0 | 6 | 3 | -1 | -11 | 14 | 1 | 0 |
11/15/12 10:02 | 11/13/12 | XOMA | Xoma Corp | DE | Health | Drug | Pharmaceutical Preparations | Wyszomierski Jack L | CA | D | | M.d | 0 | 0.00 | 3 | 4 | New | 4 | D | 9 | 69 | 6 | -13 | -26 | -17 | -3 | 0 | -2 | 4 | -2 | 1 | 58 | 54 |
12/3/03 16:37 | 12/1/03 | SGP | Schering Plough Corp | NJ | Health | Drug | Pharmaceutical Preparations | Wyszomierski Jack L | NJ | O | EVP | M.d | 0 | 0.00 | 0 | 27 | 29 | 120 | D | | | | | | | | | | | | | | |